Healthcare Value Capital’s AstraZeneca AZN Stock Holding History

Healthcare Value Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$3M	Hold	25,000	–	–	5.93%	8
2021 Q2	$3M	Buy	25,000 +12,500	+100%	+$1.37M	5.97%	7
2021 Q1	$1.24M	Buy	+12,500	New	+$1.26M	2.77%	18
2020 Q2	–	Sell	-37,500	Closed	-$3.35M	–	20
2020 Q1	$3.35M	Buy	+37,500	New	+$3.53M	5.64%	8
2015 Q4	–	Sell	-100,000	Closed	-$6.36M	–	24
2015 Q3	$6.36M	Hold	100,000	–	–	9.08%	3
2015 Q2	$6.37M	Hold	100,000	–	–	6.69%	6
2015 Q1	$6.84M	Hold	100,000	–	–	7.46%	4
2014 Q4	$7.04M	Buy	100,000 +25,000	+33%	+$1.79M	12.86%	2
2014 Q3	$5.36M	Sell	75,000 -25,000	-25%	-$1.83M	5.17%	10
2014 Q2	$7.43M	Buy	100,000 +42,761	+75%	+$3.09M	6.23%	5
2014 Q1	$3.71M	Sell	57,239 -25,000	-30%	-$1.61M	2.43%	15
2013 Q4	$4.88M	Hold	82,239	–	–	3.58%	10
2013 Q3	$4.27M	Hold	82,239	–	–	3.73%	8
2013 Q2	$3.89M	Buy	+82,239	New	+$4.19M	2.82%	11

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Healthcare Value Capital's AZN Position: Q3 2021 in Review

Healthcare Value Capital held its AstraZeneca (AZN) position steady in Q3 2021 at 25,000 shares worth $3M. The position accounts for 5.93% of the portfolio, ranked #8.

Healthcare Value Capital first reported a position in AZN in Q2 2013 and has held it in 14 quarters since. The position peaked at $7.43M in Q2 2014. 906 funds tracked by Wall St. Rank hold AZN as of Q3 2021.

Healthcare Value Capital held 25,000 shares of AstraZeneca worth $3M as of Q3 2021.
Healthcare Value Capital left its AstraZeneca share count unchanged in Q3 2021.
AstraZeneca made up 5.93% of Healthcare Value Capital's portfolio in Q3 2021, its #8 holding.
Healthcare Value Capital first reported a position in AstraZeneca in Q2 2013 and has held it in 14 quarters since.
Healthcare Value Capital's AstraZeneca position peaked at $7.43M in Q2 2014.
906 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.